Kristine Patterson, MD, Infectious Disease, Little Rock, AR, UAMS Medical Center

KristineBPattersonMD

Infectious Disease Little Rock, AR

HIV/AIDS Medicine, STD Medicine

Associate Professor

Dr. Patterson is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Patterson's full profile

Already have an account?

  • Office

    4110 Outpatient Circle
    Outpatient Center, Second Floor, Suite 2P
    Little Rock, AR 72205
    Phone(501) 603-1616
  • Is this information wrong?

Education & Training

  • University of North Carolina Hospitals
    University of North Carolina HospitalsFELLOWSHIP
  • University of Texas Medical Branch Hospitals
    University of Texas Medical Branch HospitalsRESIDENCY
  • Emory University School of Medicine
    Emory University School of MedicineMEDICAL_SCHOOL

Certifications & Licensure

  • AR State Medical License
    AR State Medical License 2019 - 2021
  • NY State Medical License
    NY State Medical License 2015 - 2019
  • NC State Medical License
    NC State Medical License 2000 - 2016
  • TX State Medical License
    TX State Medical License 1999 - 2000
  • American Board of Internal Medicine Infectious Disease

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Comparison of Tenofovir Plasma and Tissue Exposure Using a Population Pharmacokinetic Model and Bootstrap: A Simulation Study from Observed Data
    Comparison of Tenofovir Plasma and Tissue Exposure Using a Population Pharmacokinetic Model and Bootstrap: A Simulation Study from Observed DataJanuary 05, 2019 22:44

Grant Support

  • SEX, Aging And Antiretroviral PharmacologyNational Institute Of Allergy And Infectious Diseases2008–2012
  • Clinical Trial: Sex Differences In Lopinavir/Ritonavir Pharmaco Among HIV-1 MenNational Center For Research Resources2008
  • Clinical Trial: Sch47690 In Hiv-Infected, Treatment Experienced SubjectsNational Center For Research Resources2008
  • Clinical Trial: Phase II Study To Compare Twice Daily And Once Daily Therapy AndNational Center For Research Resources2008
  • Clinical Trial: Aactg 5202 - Phase IIIB Trial Of Open-Label Efavirenz Or AtazanaNational Center For Research Resources2008
  • Clinical Trial: Aactg 5188 - Phase II Transdermal Contraceptive System In HIV-1National Center For Research Resources2008
  • CID 0705 - Vaccine Screening RegistryNational Center For Research Resources2008
  • Sex Differences In Lopinavir/Ritonavir Pharmaco Among HIV-1 Men And WomenNational Center For Research Resources2007
  • Immunologic And Virologic Differences Between Pre- And Post-Men HIV WomenNational Center For Research Resources2006–2007
  • Aactg 5202 - Phase IIIB Trial Of Open-Label Efavirenz Or AtazanaviNational Center For Research Resources2006–2007
  • Aactg 5188 - Phase II Transdermal Contraceptive System In HIV-1 WomenNational Center For Research Resources2006–2007
  • Sch47690 In Hiv-Infected, Treatment Experienced SubjectsNational Center For Research Resources2005–2007
  • Phase II Study To Compare Twice Daily And Once Daily Therapy And Self-AdministerNational Center For Research Resources2005–2007
  • PK Interactions Between Dmpa, Depo-Provera And Selected Protease InhibsNational Center For Research Resources2004–2007
  • Virologic And Immunologic Changes In Hiv-Infected Women During PostpartumNational Center For Research Resources2006
  • Phase I/II Trial Of Anti-Hiv Activity Amp;Safety Of Mifepristone (Aactg 5200)National Center For Research Resources2006
  • Impact Of Therapeutic Drug Monitoring On Virologic Response To A Salvage RegimenNational Center For Research Resources2004–2006
  • Therapeutic Drug Monitoring On Virologic Response To A Salvage Regimen: AIDSNational Center For Research Resources2005

Hospital Affiliations